Please wait
0001479419 EX-FILING FEES 0001479419 2026-02-06 2026-02-06 0001479419 1 2026-02-06 2026-02-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-3

 

KALA BIO, Inc.

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type		   Security
Class
Title		   Fee Calculation or Carry Forward Rule   Amount Registered(1)     Proposed Maximum Offering Price Per Unit     Maximum Aggregate Offering Price     Fee Rate     Amount of Registration Fee     Carry Forward Form Type     Carry Forward File Number     Carry Forward Initial effective date     Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward  
Newly Registered Securities
Fees to Be Paid   Equity   Common Stock, par value $0.001 per share   Rule 457(c)     241,435,910 (2)    $ 0.4141 (3)    $ 99,978,610.33     $ 0.00013810     $ 13,807.05                                  
Fees Previously Paid                                                                                    
Carry Forward Securities
Carry Forward Securities                                                                                    
Total Offering Amounts     $ 99,978,610.33                                                  
Total Fees Previously Paid                                                          
Total Fee Offsets                                                          
Net Fee Due                     $ 13,807.05                                  

 

 

 
(1) Pursuant to Rule 416 under the Securities Act of 1933 (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock, par value $0.0001 per share (the “Common Stock”), as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
(2) Represents an aggregate of 241,435,910 shares of Common Stock consisting of (i) 12,000,010 shares of common stock issuable upon the conversion of an aggregate of 218,182 shares of Series AA Convertible Non-Redeemable Preferred Stock, (ii) 226,335,900 shares of common stock issued upon the conversion of an aggregate of 538,895 shares of Series AAA Convertible Non-Redeemable Preferred Stock, par value $0.001 per share, (iii) 2,200,000 shares of common stock issued to LifeSci Capital LLC, and (iv) an aggregate of 900,000 shares issued to Baker Brothers Life Sciences, L.P. and 667 L.P.
(3) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices of the Common Stock as reported on the Nasdaq Capital Market on February 5, 2026, which such date is within five business days of the filing of this registration statement, of $0.4141 per share.